Burning Rock Biotech (BNR) Retained Earnings (2021 - 2023)

Burning Rock Biotech has reported Retained Earnings over the past 3 years, most recently at -$22.4 million for Q4 2023.

  • Quarterly results put Retained Earnings at -$22.4 million for Q4 2023, up 95.01% from a year ago — trailing twelve months through Dec 2023 was -$22.4 million (up 95.01% YoY), and the annual figure for FY2023 was -$542.8 million, down 13.89%.
  • Retained Earnings for Q4 2023 was -$22.4 million at Burning Rock Biotech, up from -$449.9 million in the prior quarter.
  • Over the last five years, Retained Earnings for BNR hit a ceiling of -$22.4 million in Q4 2023 and a floor of -$449.9 million in Q4 2022.
  • Median Retained Earnings over the past 3 years was -$32.4 million (2021), compared with a mean of -$168.2 million.
  • Biggest five-year swings in Retained Earnings: crashed 1289.19% in 2022 and later surged 95.01% in 2023.
  • Burning Rock Biotech's Retained Earnings stood at -$32.4 million in 2021, then crashed by 1289.19% to -$449.9 million in 2022, then surged by 95.01% to -$22.4 million in 2023.
  • The last three reported values for Retained Earnings were -$22.4 million (Q4 2023), -$449.9 million (Q4 2022), and -$32.4 million (Q4 2021) per Business Quant data.